About Itä-Suomen yliopisto
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Bayer
1
Clinical Trials at Itä-Suomen yliopisto
During the past decade, Itä-Suomen yliopisto conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on
average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
2008-06-01
2013-08-01
Terminated
901
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
2008-01-01
2012-11-01
Terminated
1,100
A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients
2009-12-01
2012-11-01
Terminated
494
Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.
2020-06-15
2022-02-18
Completed
1,808
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Itä-Suomen yliopisto"
#1 collaborator was "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Itä-Suomen yliopisto
According to Clinical.Site data, the most researched conditions in "Itä-Suomen yliopisto" are
"Alzheimer Disease" (3 trials) and "Acute Non-cardioembolic Ischemic Stroke" (1 trials). Many other conditions were trialed in "Itä-Suomen yliopisto" in a lesser frequency.
Clinical Trials Intervention Types at Itä-Suomen yliopisto
Most popular intervention types in "Itä-Suomen yliopisto" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "bapineuzumab" (2 trials), "placebo" (2 trials), "BAY2433334" (1 trials), "BAY2433334 matching placebo" (1 trials) and "Bapineuzumab 0.5 mg/kg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Itä-Suomen yliopisto
The vast majority of trials in "Itä-Suomen yliopisto" are
4 trials for "All" genders.
Clinical Trials Status at Itä-Suomen yliopisto
Currently, there are NaN active trials in "Itä-Suomen yliopisto".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Itä-Suomen yliopisto,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Itä-Suomen yliopisto, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Itä-Suomen yliopisto
Itä-Suomen yliopisto has several departments that took part in Clinical trials: "Department of Neurology and Brain Research Unit, Institute of Clinical Medicine, University of Eastern Finland" - 2 trials, "Institute of Public Health and Clinical Nutrition, University of Eastern Finland" - 2 trials, "University of Eastern Finland, Brain Research Unit Mediteknia" - 2 trials
Departments List